目的为进一步研究丙型肝炎免疫发病机制、临床治疗和疫苗研制提供最接近自然感染状态的理想细胞模型。
Objective To provide a better cell model of closely nature infectious state for further understanding the immunopathogenesis, clinical treatment and vaccine development of hepatitis c.
目前尚没有丙肝疫苗,虽然联合用药可以清除丙型肝炎病毒的感染,但治疗平均有效率仅为60 %左右,并且伴有发生严重副作用的风险。
Currently, there is no vaccine for HCV, and though a combination drug regimen can clear HCV infection, this treatment is only about 60% effective on average and poses risks of severe side effects.
应用推荐